Skip Navigation
Skip to contents



13 results

Effects of Preoperative Malnutrition on Postoperative Surgical Outcomes and Quality of Life of Elderly Patients with Periampullary Neoplasms: A Single-Center Prospective Cohort Study

Kim E, Lee DH, Jang JY

  • Gut Liver.
  • 2019 Nov;13(6):690-697.
  • doi: 10.5009/gnl18469
BACKGROUND/AIMS: We investigated the effect of preoperative malnutrition on postoperative surgical outcomes in elderly patients undergoing pancreatoduodenectomy for periampullary neoplasms. METHODS: This prospective cohort study enrolled 154 patients aged ≥65 years...
Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment

Yoon KA, Woo SM, Kim YH, Kong SY, Lee MK, Han SS, Kim TH, Lee WJ, Park SJ

  • Gut Liver.
  • 2019 Nov;13(6):683-689.
  • doi: 10.5009/gnl18355
BACKGROUND/AIMS: Pancreatic ductal adenocarcinoma (PDA) is associated with an extremely poor prognosis. This study assessed the genetic diversity among patients with PDA and compared their mutational profiles before and after...
Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center

Xu L, Li L, Wang P, Zhang M, Zhang Y, Hao X, Yan L, Li B, Wen T, Xu M

  • Gut Liver.
  • 2019 Nov;13(6):669-682.
  • doi: 10.5009/gnl18489
BACKGROUND/AIMS: Microvascular invasion (MVI) is an established risk factor for hepatocellular carcinoma (HCC). However, prediction models that specifically focus on the individual prognoses of HCC patients with MVI is lacking. METHODS:...
Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease

Song DS, Chang UI, Kang SG, Song SW, Yang JM

  • Gut Liver.
  • 2019 Nov;13(6):658-668.
  • doi: 10.5009/gnl18439
BACKGROUND/AIMS: Advanced hepatic fibrosis is associated with cardiovascular disease (CVD) in patients with nonalcoholic fatty liver disease (NAFLD). We investigated the association between noninvasive serum fibrosis markers and the coronary...
Using Etomidate and Midazolam for Screening Colonoscopies Results in More Stable Hemodynamic Responses in Patients of All Ages

Lee JM, Min G, Keum B, Lee JM, Kim SH, Choi HS, Kim ES, Seo YS, Jeen YT, Chun HJ, Lee HS, Um SH, Kim CD

  • Gut Liver.
  • 2019 Nov;13(6):649-657.
  • doi: 10.5009/gnl18514
BACKGROUND/AIMS: Recent studies have demonstrated that etomidate is a safe sedative drug with noninferior sedative effects. In our recent study, we revealed that etomidate/midazolam was more hemodynamically stable than propofol/midazolam...
The Clinical Efficacy of a Pure Alginate Formulation (Lamina G) for Controlling Symptoms in Individuals with Reflux Symptoms: A Randomized Clinical Study

Kim JH, Lee YC, Kim EH, Park JC, Shin SK, Lee SK, Jung DH, Park JJ, Youn YH, Park H

  • Gut Liver.
  • 2019 Nov;13(6):642-648.
  • doi: 10.5009/gnl18378
BACKGROUND/AIMS: Bicarbonate-containing alginate formulations are reported to be effective for controlling reflux symptoms. However, the efficacy of Lamina G alginate without gas production has not been reported. The aim is...
Helicobacter pylori Infection in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Shin SP, Bang CS, Lee JJ, Baik GH

  • Gut Liver.
  • 2019 Nov;13(6):628-641.
  • doi: 10.5009/gnl18517
BACKGROUND/AIMS: Insufficient systematic reviews were conducted in the previous meta-analyses about the prevalence of Helicobacter pylori infection in patients with chronic kidney disease (CKD). The aim of this study was...
Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm

Nakanuma Y, Kakuda Y, Uesaka K

  • Gut Liver.
  • 2019 Nov;13(6):617-627.
  • doi: 10.5009/gnl18476
Intraductal papillary neoplasms of the bile duct (IPNBs) are known to show various pathologic features and biological behaviors. Recently, two categories of IPNBs have been proposed based on their histologic...
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease

Na SY, Moon W

  • Gut Liver.
  • 2019 Nov;13(6):604-616.
  • doi: 10.5009/gnl19019
New therapeutic strategies in inflammatory bowel disease (IBD) have shifted from symptom control towards treat-to-target algorithms in order to optimize treatment results. The treatment of IBD has evolved with the...
Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions

Huang RJ, Choi AY, Truong CD, Yeh MM, Hwang JH

  • Gut Liver.
  • 2019 Nov;13(6):596-603.
  • doi: 10.5009/gnl19181
Gastric intestinal metaplasia (GIM) is a known premalignant condition of the human stomach along the pathway to gastric cancer (GC). Histologically, GIM represents the replacement of normal gastric mucosa by...
New Biomarkers of Chronic Hepatitis B

Mak LY, Seto WK, Fung J, Yuen MF

  • Gut Liver.
  • 2019 Nov;13(6):589-595.
  • doi: 10.5009/gnl18425
Chronic hepatitis B (CHB) infection leads to clinically heterogeneous disease outcomes. Different viral markers are utilized to monitor treatment effects and predict risk of complications in patients with CHB. Hepatitis...
Genetic Analysis Can Surrogate the Treatment Strategies in Patients with Pancreatic Cancer

Kim DU

  • Gut Liver.
  • 2019 Nov;13(6):587-588.
  • doi: 10.5009/gnl19319
No abstract available.
Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease

Ahn JY

  • Gut Liver.
  • 2019 Nov;13(6):585-586.
  • doi: 10.5009/gnl19310
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: